204 related articles for article (PubMed ID: 7676497)
1. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.
Hornef MW; Bein G; Fricke L; Steinhoff J; Wagner HJ; Hinderer W; Sonneborn HH; Kirchner H
Transplantation; 1995 Sep; 60(5):474-80. PubMed ID: 7676497
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting reactivation of Epstein-Barr virus infection after kidney allograft transplantation.
Khameneh ZR; Soin J; Durlik M; Lao M; Paczek L; Gaciong Z
Ann Transplant; 1999; 4(2):18-22. PubMed ID: 10850586
[TBL] [Abstract][Full Text] [Related]
3. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections.
O'Neill HJ; Shirodaria PV
J Infect; 1992 May; 24(3):301-9. PubMed ID: 1318341
[TBL] [Abstract][Full Text] [Related]
4. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
Obel N; Høier-Madsen M; Kangro H
APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
[TBL] [Abstract][Full Text] [Related]
5. Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections in patients after renal transplantation.
Drouet E; Chapuis-Cellier C; Bosshard S; Verniol C; Niveleau A; Touraine JL; Garnier JL
Clin Exp Immunol; 1999 Dec; 118(3):465-72. PubMed ID: 10594569
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr viral infection in renal allograft recipients: a single center experience.
Zadeh ZR; Makhdumi K; Lak SS
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):351-4. PubMed ID: 16970255
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.
Rasmussen NS; Draborg AH; Nielsen CT; Jacobsen S; Houen G
Scand J Rheumatol; 2015; 44(2):143-9. PubMed ID: 25562120
[TBL] [Abstract][Full Text] [Related]
10. [Variability in Epstein-Barr virus serological markers in adult kidney transplant recipients].
Lauzurica R; Frías C; Bayés B; Ausina V; Romero R
Nefrologia; 2005; 25(2):185-90. PubMed ID: 15912656
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
[TBL] [Abstract][Full Text] [Related]
12. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles.
Fechtner S; Berens H; Bemis E; Johnson RL; Guthridge CJ; Carlson NE; Demoruelle MK; Harley JB; Edison JD; Norris JA; Robinson WH; Deane KD; James JA; Holers VM
Arthritis Rheumatol; 2022 Apr; 74(4):597-603. PubMed ID: 34605217
[TBL] [Abstract][Full Text] [Related]
13. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection after kidney transplantation.
Kaden J; Petersen S; Kaden K; May G
Transpl Int; 1998; 11 Suppl 1():S119-24. PubMed ID: 9664960
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
17. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis.
Stratta P; Canavese C; Ciccone G; Santi S; Quaglia M; Ghisetti V; Marchiaro G; Barbui A; Fop F; Cavallo R; Piccoli G
Nephron; 1999 Jun; 82(2):145-54. PubMed ID: 10364707
[TBL] [Abstract][Full Text] [Related]
18. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
20. INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS.
Guta S; Abrahamovych O; Abrahamovych U; Tsyhanyk L; Farmaha M
Georgian Med News; 2023 May; (338):121-125. PubMed ID: 37419485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
